drugset / Trial / NCT05236166

Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy

NCT05236166

RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective of the present study will be to establish whether a slow (within 160 days) or a rapid (within 60 days) withdrawal schedule of antiepileptic monotherapy influence relapse rate in adult patients with epilepsy, who have been seizure free for at least 2 years. Secondary objectives will be to establish the compliance rates with these two schedules and the differences in terms of severity of relapses, based on the occurrence of status epilepticus, seizure-related injuries and death.

Timeline

Start
2017-04-26
Primary completion
2021-05-01
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule
Subject Lamotrigine Small molecule
Subject Levetiracetam Other / unclassified
Subject Oxcarbazepine Small molecule
Subject Phenobarbital Unknown
Subject Phenytoin Unknown
Subject Topiramate Small molecule
Subject Valproic Acid Small molecule
Subject Zonisamide Other / unclassified

Indications